Dmitry Kaminskiy is an innovative entrepreneur and investor who is active in the fields of BioTech, FinTech, Precision Medicine, Longevity and Artificial Intelligence. Mr.Kaminskiy is a co-founder and managing partner of Deep Knowledge Ventures an investment fund focused on DeepTech and advanced science projects. He is also co-founder of Longevity.Capital, the main priorities of this fund are Longevity and AI, areas in which it has unparalleled investment and exit strategies. Dmitry Kaminskiy is a frequent speaker on the topics of AI and Longevity, including conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities. Mr.Kaminskiy serves as a managing trustee of Biogerontology Research Foundation, and Head of International Development of the Longevity International UK, Secretariat for the UK All Party Parliamentary Group for Longevity. In addition to his business experience, Dmitry is involved in several scientific endeavours. He strongly believes that humans should live longer healthier lives. He has a major interest in anti-aging and healthy longevity which is reflected in his business, research and public activities.

Margaretta Colangelo is a native San Franciscan with over 30 years of experience in executive management in software companies in Silicon Valley. She has a deep and multifaceted understanding of business, science, and technology and is highly adept at tracking and forecasting innovation in technology. Margaretta has an extensive network of connections and relationships in the startup and venture capital communities in San Francisco and New York City. She communicates frequently with top-tier media, researchers at top universities, and CEOs of AI companies. She has written over 60 articles on the topics of AI and precision medicine and publishes newsletters on DeepTech, Longevity, and Enterprise Blockchain. She has appeared in MIT Technology Review Italia, Health Management Journal, Outsourced Pharma, Pharmaceutical Executive, Healthcare IT News, Asian Robotics Review, Fierce Biotech, and Forbes multiple times. Margaretta has been at the forefront of emerging technologies throughout her entire career. In the 1990s she was a core member of the team that developed the first Java based secure messaging software for stock trading platforms that is still used today by the world's top multinational banks. She's been a core member of teams that have influenced important technical specifications and standards, including JDBC (Java Database Connectivity) and JMS (Java Messaging Service), that have helped advance the technology industry. Margaretta is a mentor and advisor to hundreds of entrepreneurs around the world, moderates sessions at AI conferences, and has over 25,000 followers on LinkedIn.